Iovance Biotherapeutics Stock Momentum Indicators Average Directional Movement Index Rating
| IOVA Stock | USD 9.40 0.28 3.07% |
| Symbol |
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average Directional Movement Index Rating (ADXR) is equal to the current ADX plus the ADX from (N) bars ago divided by 2. It is the average of the two ADX values. The ADXR of Iovance Biotherapeutics is less responsive then the ADX, and filters out excessive tops and bottoms. To interpret Iovance Biotherapeutics ADXR value, consider a high number to be a strong trend, and a low number, a weak trend.
Iovance Biotherapeutics Technical Analysis Modules
Most technical analysis of Iovance Biotherapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Iovance from various momentum indicators to cycle indicators. When you analyze Iovance charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Iovance Biotherapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Iovance Biotherapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Iovance Biotherapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Iovance Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Iovance Biotherapeutics's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Iovance Biotherapeutics's intrinsic value. In addition to deriving basic predictive indicators for Iovance Biotherapeutics, we also check how macroeconomic factors affect Iovance Biotherapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2010 | 2023 | 2024 (projected) | Dividend Yield | 0.13 | 0.12 | 0.1 | Price To Sales Ratio | 1.6K | 1.4K | 1.3K |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Iovance Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Align your values with your investing style
In addition to having Iovance Biotherapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Disruptive Technologies Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Macroaxis Index Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Cash Cows Invested few shares |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iovance Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. If investors know Iovance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iovance Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 0.327 | Quarterly Revenue Growth 123.851 | Return On Assets (0.29) | Return On Equity (0.57) |
The market value of Iovance Biotherapeutics is measured differently than its book value, which is the value of Iovance that is recorded on the company's balance sheet. Investors also form their own opinion of Iovance Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iovance Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iovance Biotherapeutics' market value can be influenced by many factors that don't directly affect Iovance Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iovance Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.